Navigation Links
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Date:10/31/2011

expenses71,38358,85021.3%Operating income 18,56628,905(35.8%)Interest expense(17)(23)(26.1%)Interest income74949351.9%Other (expense), net(287)(216)32.9%Income before taxes19,01129,159(34.8%)Tax expense5,1317,821(34.4%)NET INCOME$ 13,880$ 21,338(35.0%)Net income per common shareassuming dilution$0.54$0.85(36.2%)Weighted average number of sharesBasic25,41824,686Diluted25,84325,228Profit Margins:Inc/(Dec) vs
prior year profit
margin % Gross profit50.1%52.6%(2.5%)R&D5.8%4.8%1%S,G&A34.9%31.6%3.3%Operating income10.3%17.3%(7.0%)Income before taxes10.6%17.5%(6.9%)Net income7.7%12.8%(5.1%)Consolidated Statements of Income for Year-to-Date FY12 and FY1110/1/2011
As Reported10/2/2010
As Reported% Inc/(Dec) vs
Prior YearNET REVENUES$ 350,014$ 329,8726.1%Gross profit178,698174,2172.6%R&D18,95915,87519.4%S,G&A118,844107,14410.9%Contingent consideration income(1,580)(1,894)(16.6%)Operating expenses136,223121,12512.5%Operating income 42,47553,092(20.0%)Interest expense(35)(40)(12.5%)Interest income76746066.7%Other (expense)/income, net(502)22(2381.8%)Income before taxes42,70553,534(20.2%)Tax expense11,87714,277(16.8%)NET INCOME$ 30,828$ 39,257(21.5%)Net income per common shareassuming dilution$1.18$1.54(23.4%)Weighted average number of sharesBasic25,57524,913Diluted26,02925,459Profit Margins:Inc/(Dec) vs
prior year profit
margin % Gross profit51.1%52.8%(1.7%)R&D5.4%4.8%0.6%S,G&A34.0%32.5%1.5%Operating income12.1%16.1%(4.0%)Income before taxes12.2%16.2%(4.0%)Net income8.8%11.9%(3.1%)Revenue Analysis for the Second Quarter and Year-To-Date FY12 and FY11Three Months Ended10/1/2011
As Reported10/2/2010
As Reported% Inc/(Dec) vs
Prior YearRevenues by geographyUnited States

$ 86
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
2. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
3. Haemonetics to Present at J.P. Morgan Healthcare Conference
4. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
5. Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
6. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
7. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
8. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2011
10. ERT Reports Third Quarter 2011 Operating Results
11. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: ... and Canada , is teaming with ... La Diabetes: Logra Tus Metas , an educational program encouraging Hispanics ... sugar -- a key treatment goal to help reduce the risk ... are at a higher risk for developing type 2 ...
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select ... Three clinics opened in Memphis and ... be added in Springfield on September 24 ... expected to open October 22.  MinuteClinic is the largest and fastest ... States . The Memphis -area ...
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... IDEV Technologies, Incorporated (IDEV), an innovative leader in ... technologies, today announced the release of two-year European ... patients treated with the SUPERA wire interwoven nitinol ... biliary and peripheral vascular use in Europe.  In ...
... 26, 2011 The Global Coalition on Aging announced ... raise awareness and address the social and economic impact ... of America Merrill Lynch, Galderma, Intel, Johnson & Johnson, ... LLP is serving as an advisory member. ...
Cached Medicine Technology:Long-Term European Data Released for SUPERA® Stent from IDEV Technologies 2Long-Term European Data Released for SUPERA® Stent from IDEV Technologies 3Long-Term European Data Released for SUPERA® Stent from IDEV Technologies 4'Global Coalition on Aging' Launches as 450 Million People Turn 65 Over Next Two Decades 2'Global Coalition on Aging' Launches as 450 Million People Turn 65 Over Next Two Decades 3
(Date:9/19/2014)... On September 16, Camino Public Relations ... and Top Places to Work in PR Awards Luncheon ... received honorable mentions in two categories for “Multicultural Campaign” ... elevating Latina voices in the media. , "We're honored ... part of its efforts to improve the national conversation ...
(Date:9/19/2014)... NY (PRWEB) September 19, 2014 According ... manufacturers of the embattled blood-thinner Xarelto, named as defendants ... of Common Pleas, have moved the court to dismiss ... do not have sufficient connection with Philadelphia.* The cases ... et al. (No. 140304328; Pa. Comm. Pls., Philadelphia Cty.), ...
(Date:9/19/2014)... 19, 2014 (HealthDay News) -- Although there is ... benefits, most middle-aged and older adults in the ... exercise, according to new research. Less than ... recommendations set by the Department of Health and ... is essential for promoting health and fitness and ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 MetroMD, a leading ... the “God Particle” of human health. This therapy has grown ... making the therapy more effective, safe and dependable. It has ... them an opportunity to live a very healthy and active ... concept of HGH therapy, a senior therapist at MetroMD said, ...
(Date:9/19/2014)... Domestic violence occurs at least as frequently, and ... to opposite-sex couples, according to a review of ... Previous studies, when analyzed together, indicate that domestic ... lesbian, gay and bisexual individuals. However, a lack ... an incomplete picture of the true landscape, suggesting ...
Breaking Medicine News(10 mins):Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:Domestic violence likely more frequent for same-sex couples 2
... Mercedes Walton, CEO of Cryo-Cell International, one of the ... progress to date and encouraging continued momentum for existing bills through ... Cord Blood Banking Act," and H.R. 2107, the "Cord Blood Education ... progress from the first half of the year to enable and ...
... Sociological Association,s 104th annual meeting, will be the subject ... present research and explore the politics, history, health and ... More than 5,000 sociologists will convene in the ... New Politics of Community," the meeting,s theme. In addition ...
... , SAN DIEGO, July 6 ADVENTRX Pharmaceuticals, Inc. ... it has completed the previously announced sale of shares ... to a registered direct offering to a single institutional ... percent, or approximately $340,250, of the gross proceeds will ...
... showed muscle fiber damage even after halting drugs, researchers say ... used to lower cholesterol, may cause structural damage to the ... study has found. , The damage may occur even when ... and may persist even after statin use is halted, according ...
... Eli Lilly and Company (NYSE: LLY ) will ... Wednesday, July 22, 2009. Lilly will also conduct a conference ... further detail the company,s financial performance. , , The ... EDT. Investors, media and the general public can access a ...
... Inc. (Nasdaq: SLTM ), a global leader in ... an amendment with Silicon Valley Bank, a member company of ... the company,s credit facility has been expanded from $9 million ... the secured revolving loan facility to $8.0 million, an amendment ...
Cached Medicine News:Health News:Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood 2Health News:Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood 3Health News:Sociologists to turn the sociological eye on San Francisco 2Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 2Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 3Health News:ADVENTRX Pharmaceuticals Announces Closing of Financing 4Health News:Statins May Cause Muscle Damage in Some Patients 2Health News:Statins May Cause Muscle Damage in Some Patients 3Health News:Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 2Health News:Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 3
... process makes use of ... magnetic responsiveness. The superparamagnetic ... rigid core structure ensures ... occurs upon removal of ...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
Streptavidin MicroBeads are used for the indirect magnetic labeling and separation of cells, subcellular material, or bacteria labeled with a biotinylated primary antibody or ligand....
... beads are 1 m ... to a form of ... be useful as ligands ... mRNA isolation and the ...
Medicine Products: